Cargando…

NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation

NLRC3 inhibits inflammatory responses. Neuroinflammation induces and accelerates the onset of Alzheimer's disease (AD). This study is aimed at investigating whether NLRC3 plays a role in neuroinflammation, Aβ accumulation, and neuroprotection in AD mice. 12-month-old APP/PS1 transgenic and C57...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zha, Lihuang, Yu, Zaixin, Fang, Jian, Zhou, Li, Guo, Wen, Zhou, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775163/ https://www.ncbi.nlm.nih.gov/pubmed/33425209 http://dx.doi.org/10.1155/2020/5328031

Ejemplares similares

NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
por: Karki, Rajendra, et al.
Publicado: (2016)

NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis
por: Zha, Li-huang, et al.
Publicado: (2018)

NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer
por: Fan, Yijun, et al.
Publicado: (2020)

Neuroprotective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice
por: Yang, Cui-Zhu, et al.
Publicado: (2023)

Tanshinone IIA Alleviates the AD Phenotypes in APP and PS1 Transgenic Mice
por: Li, Fengling, et al.
Publicado: (2016)

NLRP3, NLRC4 and NLRC5 Gene Polymorphisms Associate with Susceptibility of Pulmonary Aspergillosis in Non-Neutropenic Patients
por: Zhong, Jinjin, et al.
Publicado: (2022)

Qingxin Kaiqiao Recipe Improves Cognitive Performance, Inhibits Apoptosis, and Reduces Pathological Deposits in APP/PS1 Double Transgenic Mice via the PI3K/Akt Pathway
por: Lin, Shi-Yi, et al.
Publicado: (2020)

The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway
por: Yuan, Ye, et al.
Publicado: (2023)

Fluoxetine Promotes Hippocampal Oligodendrocyte Maturation and Delays Learning and Memory Decline in APP/PS1 Mice
por: Chao, Feng-lei, et al.
Publicado: (2021)

Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice
por: DeSantis, David A., et al.
Publicado: (2013)

Nlrc3 Knockout Mice Showed Renal Pathological Changes After HTNV Infection
por: Ma, Ruixue, et al.
Publicado: (2021)

Sex Differences in the White Matter and Myelinated Fibers of APP/PS1 Mice and the Effects of Running Exercise on the Sex Differences of AD Mice
por: Zhou, Chun-ni, et al.
Publicado: (2018)

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
por: Li, Tangzhiming, et al.
Publicado: (2019)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
por: Dickey, Chad A, et al.
Publicado: (2005)

Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome
por: Sim, JeongMin, et al.
Publicado: (2022)

NAIP–NLRC4-deficient mice are susceptible to shigellosis
por: Mitchell, Patrick S, et al.
Publicado: (2020)

NLRP3 recruitment by NLRC4 during Salmonella infection
por: Qu, Yan, et al.
Publicado: (2016)

The evolution of NLRC3 subfamily genes in Sebastidae teleost fishes
por: Gao, Chengbin, et al.
Publicado: (2023)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

Echinacoside Improves Cognitive Impairment by Inhibiting Aβ Deposition Through the PI3K/AKT/Nrf2/PPARγ Signaling Pathways in APP/PS1 Mice
por: Qiu, Hui, et al.
Publicado: (2022)

Physics at the AD/PS/SPS (3/4)
por: Ceccucci, Augusto
Publicado: (2012)

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse
por: Wang, Shang, et al.
Publicado: (2023)

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012)

An inherited mutation in NLRC4 causes autoinflammation in human and mice
por: Kitamura, Akiko, et al.
Publicado: (2014)

LDL-induced NLRC3 inflammasome activation in cardiac fibroblasts contributes to cardiomyocytic dysfunction
por: Wang, Peng, et al.
Publicado: (2021)

Role of PI3K in the Progression and Regression of Atherosclerosis
por: Zhao, Yunyun, et al.
Publicado: (2021)

AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway
por: Sun, Xiaojin, et al.
Publicado: (2021)

SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation
por: Guan, Chenyang, et al.
Publicado: (2021)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

Study on myelin injury of AD mice treated with Shenzhiling oral liquid in the PI3K/Akt–mTOR pathway
por: Wang, Yahan, et al.
Publicado: (2020)

Overexpression of FGF2 delays the progression of osteonecrosis of the femoral head activating the PI3K/Akt signaling pathway
por: Lu, Pei, et al.
Publicado: (2021)

Evidence for B(1220) production in an analysis of the reaction K− d→ps $\lambda \pi^{+} \pi^{-} \pi^{-} \pi^{0}$ at 3 GeV/c
por: Hoogland, W, et al.
Publicado: (1970)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019)

EGCG and nimodipine improve the symptoms of AD by inhibiting [Ca2+]i in hippocampal neurons of APP/PS1 transgenic mice
por: Wang, Shuang, et al.
Publicado: (2012)

Tat-haFGF(14–154) Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway
por: Meng, Tian, et al.
Publicado: (2017)

Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
por: Zhang, Xueju, et al.
Publicado: (2020)

Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes
por: Sebastian-Valverde, Maria, et al.
Publicado: (2021)

Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice
por: Li, Guohua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04nki07n476m2ah71g8i164jdt